Xu Zheng

Xu Zheng focuses his practice on capital markets and a variety of general corporate matters. He has been involved in significant corporate and investment projects in a variety of industries, including finance (including fintech), health care, technology, media and telecom.

Mr. Zheng joined Skadden in 2016 after previously working at another major U.S. law firm. His representations (including those from his prior firm) include:

• YSB Inc. in its US$40 million IPO and listing on the Hong Kong Stock Exchange (HKEX)
• MINISO Group Holding Limited in its US$72 million offering of Class A ordinary shares and dual-primary listing on HKEX
• Transcenta Holding Limited in its US$83 million IPO and listing on HKEX
• ATRenew Inc. in its US$227 million U.S. IPO and listing on the New York Stock Exchange (NYSE)
• Zhihu Inc. in its US$523 million U.S. IPO and listing on the NYSE
• MINISO Group Holding Limited in its US$608 million U.S. IPO and listing on the NYSE
• Neusoft Education Technology Co. Limited in its US$134 million IPO and listing on HKEX
• China Renaissance Holdings Limited in its US$350 million IPO and listing on HKEX
• Huya Inc. in its US$326 million follow-on offering of American depositary shares
• Xiaomi Corporation in its US$5.4 billion IPO and listing on HKEX
• E-House (China) Holdings Limited in its US$595 million IPO and listing on HKEX
• China Education Group Holdings Limited in its US$430 million IPO and listing on HKEX
• PPDAI Group Inc. in its US$221 million U.S. IPO and listing on the NYSE, and a concurrent US$50 million private placement of Class A ordinary shares to Sun Hung Kai & Co. Limited
• the joint sponsors in the US$408 million IPO and listing on HKEX of Hope Education Group Co., Ltd.
• RYB Education, Inc. in its US$144 million U.S. IPO and listing on the NYSE
• People’s Insurance Company of China in its US$3.6 billion IPO and listing on HKEX
• China Cinda Asset Management Co., Ltd. in its US$2.3 billion IPO and listing on HKEX
• China International Capital Corporation in its US$708 million IPO and listing on HKEX
• Agricultural Bank of China Limited on HKEX compliance issues in relation to its US$6.6 billion offering of preferred shares
• iKang Guobin Healthcare Inc. in its US$153 million U.S. IPO and listing on Nasdaq
• Xunlei Limited in its US$101 million U.S. IPO and listing on Nasdaq
• Wanhua Chemical International in its RMB1 billion Regulation S guaranteed senior notes offering
• Sinopec in its US$3 billion Regulation S/Rule 144A guaranteed notes offering
• China Cinda Asset Management Co., Ltd. in its US$1.5 billion Regulation S/Rule 144A guaranteed senior notes offering